Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients

NCT04117477 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

46

Enrollment

OTHER

Sponsor class

Stopped A new multisite study was opened in place of this study.

Conditions

Allogeneic Hematopoietic Cell Transplantation

Interventions

DRUG: Xylitol
OTHER: Placebo

Sponsor

Children's Hospital Medical Center, Cincinnati